Prize for glaucoma breakthrough

  • May 12, 2015
Prize for glaucoma breakthrough

Paper which marks a breakthrough in glaucoma research wins ophthalmology award.

The work helps not only to bring potential stem cell-based therapies for neurodegenerative disease closer to clinical translation, but also identifies new pathways that could be targeted by pharmaceutical approaches.

Thomas Johnson

A paper by a Gates Cambridge alumnus on a novel mechanism by which stem cell transplantation may help to prevent glaucoma has won top prize at a prestigious ophthalmology awards ceremony.

The research by Thomas V Johnson won first place at the Association for Research In Vision and Ophthalmology (ARVO)/Merck Innovative Ophthalmology Research Awards. 

Published in the journal Brain, the paper is based on work Thomas did as a Gates Cambridge Scholar as well as subsequent research and is part of a collaboration between the University of Cambridge’s John van Geest Centre for Brain Repair and the National Institutes of Health’s National Eye Institute in the United States.

Dr Johnson’s research focuses on glaucoma, a neurodegenerative disease of the optic nerve, the “cable” which carries visual information from the retina in the eye to the brain.  Glaucoma causes the progressive loss of retinal ganglion cells, which make up the optic nerve, eventually leading to vision loss and potentially blindness.  Previous research by Dr Johnson showed that transplantation of stem cells from the bone marrow into the eye could protect the optic nerve in a rodent model of glaucoma, but the mechanism by which that protection occurs was unclear.

It demonstrates that bone marrow-derived mesenchymal stem cells produce and secrete a large number of proteins that each individually help to protect retinal ganglion cells from stress and cell death.  Together, the additive effect of these proteins (the stem cell “secretome”) appears to confer potent neuroprotection.  Dr Johnson’s team identified one particularly strong neuroprotective factor, platelet-derived growth factor or PDGF, that, when injected into a glaucomatous eye on its own, protected almost 90% of the optic nerve fibres that otherwise would have degenerated.

Dr Johnson [2006], who did his PhD in Brain Repair, says: "The work helps not only to bring potential stem cell-based therapies for neurodegenerative disease closer to clinical translation, but also identifies new pathways that could be targeted by pharmaceutical approaches."

Dr Johnson is currently based at the Johns Hopkins School of Medicine.

Latest News

The process of history-making

Olin Moctezuma-Burns [2020] is keen not to repeat the patterns of some past researchers and to give back to the communities she studies. For that reason she recently co-organised an international gathering of Imagining Futures projects on archiving indigenous and traditional knowledges in Sotuta, Yucatan. The meeting brought together people from Colombia, Peru, Kenya, Tanzania, […]

How might extreme heat contribute to human migration?

Rising temperatures due to climate change are likely influencing human migration patterns, according to a new study co-authored by Gates Cambridge Scholar Dr Kim van Daalen [2018]. The study, led by Rita Issa of University College London, is published today in the open-access journal PLOS Climate. It looks at the role of heat in human […]

Scholar scoops prestigious science innovation fellowship

Freja Ekman has been named one of the 2023 class of Hertz Fellows as the prestigious fellowship celebrates its 60th year. The 15 fellowships in applied science, engineering and mathematics are awarded by Fannie and John Hertz Foundation, a non-profit organisation for innovators in science and technology. Winners will have their graduate studies funded for […]

Scholar hosts first UN communications technology access meeting in India

Gates Cambridge Scholar Pradipta Biswas has hosted a UN meeting on improving access to communications technology – the first ever held in India. The meeting of ITU-T Study Group 9 (SG-9) on “Broadband Cable and Television/Audiovisual content transmission and integrated broadband cable networks”  was held in May at the Indian Institute of Science in Bengaluru […]